PepGen Inc. (NASDAQ:PEPG)
| Market Cap | 379.03M+28.6% |
| Revenue (ttm) | 0 |
| Net Income | -73.31M+21.6% |
| EPS | -1.23+56.8% |
| Shares Out | 69.17M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 76,581,695 |
| Open | 5.54 |
| Previous Close | 2.39 |
| Day's Range | 5.15 - 6.49 |
| 52-Week Range | 1.31 - 7.80 |
| Beta | 2.02 |
| Analysts | Buy |
| Price Target | 4.00(-27.00%) |
| Earnings Date | Nov 11, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About PEPG
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
1 firm rating PEPG in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Nov 11, 2026Earnings report
$PEPG stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in PEPG holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PEPG's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PEPG Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New PEPG patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PEPG from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in PEPG
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $3.41M |
| VXFVanguard Extended Market ETF | $1.26M |
| IBBiShares Biotechnology ETF | $1.17M |
| IWCiShares Micro-Cap ETF | $305.47K |
| BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF | $200.00K |
| AVSCAvantis U.S. Small Cap Equity ETF | $130.41K |
Estimated from each fund’s disclosed top holdings × AUM
PEPG Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from PEPG’s recent data — informational, not investment advice